Bioextrax AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 0.12 million compared to SEK 0.052334 million a year ago. Revenue was SEK 0.487539 million compared to SEK 0.334326 million a year ago. Net loss was SEK 4.6 million compared to SEK 2.56 million a year ago. Basic loss per share from continuing operations was SEK 0.3034 compared to SEK 0.1813 a year ago.
For the nine months, sales was SEK 0.362474 million compared to SEK 0.092334 million a year ago. Revenue was SEK 1.4 million compared to SEK 0.40061 million a year ago. Net loss was SEK 12.87 million compared to SEK 7.63 million a year ago. Basic loss per share from continuing operations was SEK 0.8492 compared to SEK 0.5403 a year ago.